Furthermore, the percentage of PD‐1 cells with CD8+ T cells was significantly lower than that in the tumor control group, with percentages of 22.46 ± 2.71% and 30.16 ± 4.14% (P < 0.01 and P < 0.05), respectively. Here, CD8A is linked to neoplasm.